Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device maker Vascular Solutions (VASC) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at Vascular and see what CAPS investors are saying about the stock right now.
Vascular facts
Headquarters (founded) |
Minneapolis, Minn. (1996) |
Market Cap |
$273.3 million |
Industry |
Health care supplies |
Trailing-12-Month Revenue |
$102.6 million |
Management |
Co-Founder/CEO Howard Root |
Return on Equity (average, past 3 years) |
21.5% |
Cash / Debt |
$19.7 million / $0 |
Competitors |
Abbott Labs |
Just yesterday, CAPS member rknapton succinctly summed up the Vascular outperform case for our community: "Long. Medical instruments company. Nice steady growth. Buying back stock. Cash flow from operating activities growing. Earnings grew 17% on a 9% boost in revenues last quarter. Not bad here at 21x fwd estimates."
If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong five-star rating, Vascular may not be your top choice.